Imax (IMAX) Given Buy Rating at B. Riley

B. Riley reissued their buy rating on shares of Imax (NYSE:IMAX) in a research note released on Monday, November 20th. The firm currently has a $35.00 price target on the stock.

IMAX has been the topic of a number of other research reports. Barrington Research raised Imax from a market perform rating to an outperform rating and set a $32.00 price objective on the stock in a research report on Monday, October 30th. Zacks Investment Research raised Imax from a sell rating to a strong-buy rating and set a $28.00 price objective on the stock in a research report on Wednesday, November 1st. J P Morgan Chase & Co raised Imax from a neutral rating to an overweight rating in a research report on Friday, October 27th. Wedbush reissued a buy rating and issued a $31.00 price target on shares of Imax in a report on Friday, October 27th. Finally, Credit Suisse Group lowered their price target on Imax from $26.00 to $25.00 and set a neutral rating for the company in a report on Thursday, September 28th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of Buy and an average price target of $31.00.

Imax (NYSE IMAX) traded down $0.15 during trading hours on Monday, reaching $23.75. The company had a trading volume of 865,338 shares, compared to its average volume of 1,104,822. Imax has a one year low of $17.58 and a one year high of $34.60. The stock has a market cap of $1,570.31, a price-to-earnings ratio of 101.04, a PEG ratio of 3.60 and a beta of 1.13.

Imax (NYSE:IMAX) last released its earnings results on Thursday, October 26th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.07. Imax had a return on equity of 2.62% and a net margin of 1.78%. The business had revenue of $98.80 million for the quarter, compared to analyst estimates of $86.17 million. During the same quarter last year, the firm posted $0.12 earnings per share. The business’s revenue was up 14.2% compared to the same quarter last year. equities analysts forecast that Imax will post 0.3 EPS for the current year.

In other news, insider Mark Welton sold 8,985 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $25.81, for a total value of $231,902.85. Following the completion of the transaction, the insider now directly owns 16,331 shares in the company, valued at $421,503.11. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 18.90% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the stock. Legal & General Group Plc raised its position in Imax by 0.6% during the second quarter. Legal & General Group Plc now owns 21,109 shares of the company’s stock valued at $468,000 after acquiring an additional 129 shares in the last quarter. MML Investors Services LLC raised its position in Imax by 0.5% during the second quarter. MML Investors Services LLC now owns 31,735 shares of the company’s stock valued at $698,000 after acquiring an additional 166 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Imax by 13.0% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,522 shares of the company’s stock valued at $181,000 after acquiring an additional 748 shares in the last quarter. Denver Investment Advisors LLC raised its position in Imax by 8.3% during the second quarter. Denver Investment Advisors LLC now owns 26,265 shares of the company’s stock valued at $578,000 after acquiring an additional 2,015 shares in the last quarter. Finally, UBS Group AG raised its position in Imax by 19.2% during the first quarter. UBS Group AG now owns 15,112 shares of the company’s stock valued at $513,000 after acquiring an additional 2,435 shares in the last quarter. Institutional investors own 83.95% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Imax (IMAX) Given Buy Rating at B. Riley” was first published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.thelincolnianonline.com/2017/12/07/imax-corporation-imax-rating-reiterated-by-b-riley-updated-updated.html.

Imax Company Profile

IMAX Corporation is an entertainment technology company. The Company operates through seven segments: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production, and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment.

Analyst Recommendations for Imax (NYSE:IMAX)

Receive News & Ratings for Imax Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imax Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply